More adjustments to US Food and Drug Administration hiring initiatives appear necessary for the prescription drug user fee reauthorization, but an agreement on changes does not appear as close as some other topics.
Additional improvements may come down to progress measurements. Industry representatives and agency officials agreed during a PDUFA VII negotiating session...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?